Bids Are Invited For Acquisition Of Oncological Medications, In Accordance With The Conditions And Requirements Established In The Notice.

Abemaciclib, Abiraterone Acetate, Acalabrutinib, Afatinib Dimaleate, Alectinib, Alpelisib, Anagrelide Hydrochloride, Anastrozole, Apalutamide, Aprepitant, Axitinib, Baricitinib, Bicalutamide, Bosentan, Brigatinib, Cabozantinib, Capecitabine, Capmatinib, Cyclophosphamide, Cyclosporine, Cyproterone Acetate, Clo Rambucil, Cobimetinib Hemifumarate , Crizotinib, Dabrafenib, Darolutamide, Dasatinib, Deferasirox, Duloxetine, Eltrombopag Olamine, Entecavir, Enzalutamide, Erdafitinib, Erlotinib, Everolimus, Exemestane, Fexofenadine, Flutamide, Gefitinib, Gilteritinib, Hydroxyurea, Ibrutinib, Imatinib Mesylate, Ixazomib, Lapatinib, Lar Otrectinib, Leflunomide , Lenalidomide, Lenvatinib, Letrozole, Lomustine, Lorlatinib, Macrogol, Megestrol Acetate, Melphalan, Mercaptopurine, Mesalazine, Mesna, Methotrexate, Midostaurin, Mitotane, Montelukast Sodium, Morphine, Palonosetron Hydrochloride, Nilotinib, Nintedanib, Niraparib, Olaparib, Osimertinib, Oxycodine At Cloridrato , Palbociclib, Ponatinib, Regorafenib, Ribociclib, Ruxolitinib, Sorafenib Tosylate, Sunitinib, Tamoxifen Citrate, Temozolomide, Tofacitinib, Thioguanine, Trametinib, Tretinoin, Trifluridine, Valganciclovir Hydrochloride, Vandetanib, Vemurafenib, Venetoclax, Vinorelbine, Vismodegib, Voriconazole , Zanubrutinib, Pazopanib